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Iron deficiency is a common health problem. The
most severe consequence of this disorder is iron de-
ficiency anemia (IDA), which is considered the most
common nutritional deficiency worldwide. Newborn
piglets are an ideal model to explore the multifaceted
etiology of IDA in mammals, as IDA is the most prev-
alent deficiency disorder throughout the early post-
natal period in this species and frequently develops
into a critical illness. Here, we report the very low
expression of duodenal iron transporters in pigs dur-
ing the first days of life. We postulate that this low
expression level is why the iron demands of the piglet
body are not met by iron absorption during this pe-
riod. Interestingly, we found that a low level of duo-
denal divalent metal transporter 1 and ferroportin,
two iron transporters located on the apical and baso-
lateral membrane of duodenal absorptive enterocytes,
respectively, correlates with abnormally high expres-
sion of hepcidin, despite the poor hepatic and overall
iron status of these animals. Parenteral iron supple-
mentation by a unique intramuscular administration
of large amounts of iron dextran is current practice
for the treatment of IDA in piglets. However, the poten-
tial toxicity of such supplemental iron implies the ne-
cessity for caution when applying this treatment. Here
we demonstrate that a modified strategy for iron sup-
plementation of newborn piglets with iron dextran im-
proves the piglets’ hematological status, attenuates
the induction of hepcidin expression, and minimizes
the toxicity of the administered iron. (Am J Pathol
2010, 177:000–000; DOI: 10.2353/ajpath.2010.091020)
Iron deficiency is the most frequent cause of anemia in
humans,1 and iron deficiency anemia (IDA) is most prev-
alent in the neonatal period and early childhood.2 Early
postnatal iron deficiency is also a widespread phenom-
enon in other mammalian species. Indeed, IDA has long
been recognized as a serious iron disorder in livestock,
especially in suckling piglets.3 In contrast to humans and
mice, the complex molecular regulation of body iron ho-
meostasis4 has been the subject of few studies in pigs.5–7
Our knowledge of iron homeostasis in newborn pigs is
mostly based on physiological concepts stemming from
the early 1990s. Although the pig is a major biomedical
mammalian model for human studies,8 its contribution to
understanding the molecular pathophysiological mecha-
nisms of human iron disorders has so far been small.9
The common reason for iron deficiency in newborn
piglets is their rapid growth, particularly the increase in
blood volume and the number of red blood cells (RBCs).
Indeed, erythroid precursors in the bone marrow use
most of the iron found in the plasma for the synthesis of
hemoglobin. As sow’s milk largely provides piglets with
iron below their daily requirements,10 an exogenous
source of iron is essential to prevent the reduction in RBC
hemoglobin level. Intramuscular administration of large
amounts of iron dextran (FeDex) on days 3 to 6 postpar-
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tum is current practice in the swine industry,3,11 and has
been proven to rectify the hematological status of piglets.
However, it seems unlikely that 100 to 200 mg of iron (a
commonly applied dose) given in a single injection to a
piglet with only about 40 to 50 mg of iron in its body at
birth,12 is efficiently metabolized and detoxified. More-
over, high parenteral intake of supplemental iron may
easily perturb the tight control of systemic iron metabolic
processes. In this context, iron supplementation in piglets
raises the question of the role of hepcidin (Hepc)—the
systemic iron-regulatory hormone13 in the regulation of
natural intestinal iron absorption, especially under condi-
tions of morphological and functional rebuilding of the pig
small intestinal mucosa that occurs within 21 days of
birth.14
In this study we examined the expression of proteins
involved in iron absorption and its regulation in newborn
piglets during the first 2 weeks of life. We also tested a
modified strategy for iron supplementation of anemic pig-
lets and demonstrated its ability to improve their hema-
tological status, regulate Hepc expression and minimize
the toxicity of supplemental iron.
Materials and Methods
Animals, Experimental Design, and Biological
Sample Collection
Experiments were conducted at the State pig farm (Do-
brzyniewo, Poland). A total of 64 Polish Landrace 
Pietrain piglets housed in standard conditions (approx.
70% humidity and a temperature of 22  2°C in standard
cages with straw bedding) were used in the experiments.
Piglets were taken from 11 litters delivered by 8 primipara
and 3 multipara sows. During the 14-day experiment,
sows were allowed to nurse their piglets. The number of
piglets taken from each litter was from 4 to 8 depending
on the litter size (10 to 16 piglets). They were allotted to
one of three different experimental groups on the basis of
body weight (b.w.) at the given experimental age (Figure
1): A) control piglets receiving no iron supplementation;
B) piglets intramuscularly injected in the neck with 100
mg Fe/kg b.w. on day 3 postpartum (traditional supple-
mentation); and C) piglets injected with 40 mg Fe/kg b.w.
on day 3 and again on day 10 postpartum (modified
supplementation). Iron was administered to piglets in the
form of iron dextran (FeDex), a complex of ferric ions with
low molecular weight dextran (Ferran 100, 10% solution,
Vet-Agro, Lublin, Poland). Biological samples were col-
lected from control piglets (group A) at the age of 1, 2, 4,
7, and 14 days and from iron-supplemented animals
(groups B and C) at the age of 4, 7, and 14 days. Piglets
were sacrificed for tissue sampling (5 to 6 animals for
each time point) by CO2 inhalation and exsanguination.
Immediately after death, liver fragments were excised
and scrapings from the proximal duodenum were col-
lected. Samples were frozen in liquid nitrogen and held at
80°C until they were analyzed. The experiments de-
scribed here were conducted in compliance with the
European Union regulations concerning the protection of
experimental animals. All procedures were approved by
the third Local Ethical Commission in Warsaw (permis-
sion no. 46/2003).
Hematological Analysis and Serum Iron
Blood was drawn from piglets into heparinized tubing by
direct cardiac puncture immediately after death. Erythro-
cyte counts and erythrocyte parameters as well as serum
iron levels were determined using an automated SYMEX
F820 Analyzer.
Quantitative Hepatic Non-Heme Iron
Measurement and Hepatic Iron Staining
Quantification of the non-heme iron content of liver frag-
ments (100 mg) was performed using a BIOCHEMTEST
(Polish Chemical Reagents, Gliwice, Poland) as de-
scribed previously.15
Pig livers were fixed in Bouin’s solution for 72 hours at
20°C and then stored in 70% ethanol before further prep-
aration. After dehydration liver fragments were embed-
ded in paraffin and cut into 5 m sections with rotation
microtome (Microm HM 355S, MICROM GmbH, Ger-
many). After mounting on glass slides, sections were
deparaffinized, stained with Perls’ Prussian blue, coun-
terstained with nuclear red and analyzed under light mi-
croscope (Zeiss).
Detection of Iron-Saturated Ferritin by
Polyacrylamide Gel Electrophoresis
The detection of ferritin was performed using a procedure
for the identification of iron-binding proteins.16 Briefly, 80
g samples of liver membrane extract were resolved by
electrophoresis on 7% polyacrylamide gels under non-
denaturing conditions. The gels were then immediately
placed in potassium ferricyanide solution (2% in 50
mmol/L Tris-HCl, 100 mmol/L NaCl, pH 7.5), held in the
dark for 15 minutes and then transferred to trichloroacetic
acid/methanol solution. Iron-containing ferritin was visu-
alized as blue bands in the native gels. To detect total
14
100 mg Fe/kg b.w.
4 7
3 4 147
1 2
10
40 mg Fe/kg b.w.
days after birth
Fe 40 mg/kg b.w.
4 1473
A
B
C
no Fe supplementation
Figure 1. Experimental design scheme. Numbers indicate the age of piglets
at which animals were sacrificed and biological samples collected. Boxed
numbers indicate the days on which iron dextran supplementation was
given.
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ferritin level in the liver, hepatic membrane extracts (45
g/lane) were separated on non-denaturing polyacryl-
amide gel electrophoresis (PAGE), and stained with Coo-
massie blue. To assist identification of Ft bands horse
spleen holo- and apo-Ft were used as positive controls
(electrophoresed on the same gel).
Real-Time Quantitative Reverse
Transcription-Polymerase Chain Reaction
Analysis of mRNA Abundance
Total cellular RNA was extracted from liver samples (20
mg) using TRIzol reagent (Invitrogen) according to the
manufacturer’s protocol. Two micrograms of total DNase-
treated RNA were used for reverse transcription with
MMLV reverse transcriptase (Promega) at 45°C for 1
hour. Real-time quantitative reverse transcription (RT)-
PCR of cDNAs derived from specific transcripts was
performed in a Light Cycler (Roche Diagnostics, Mann-
heim, Germany) using the respective pairs of oligonucle-
otide primers indicated in Table 1. Amplification products
were detected using SYBR Green I (Roche Diagnostics)
as described previously.17 To confirm amplification spec-
ificity, the PCR products from each primer pair were
subjected to melt curve analysis and agarose gel elec-
trophoresis. Light Cycler 3.5 Software was used for data
analysis. Expression was normalized relative to that of
control transcripts encoding glyceraldehyde-3-phos-
phate dehydrogenase or 18S rRNA.
Western Blot Analysis
For the detection of duodenal divalent metal transporter 1
(DMT1) and ferroportin (Fpn), 100 g of membrane ex-
tracts from duodenal mucosa scrapings were done as
previously described18 and were resolved by electro-
phoresis on 10% SDS-polyacrylamide gels. For the de-
tection of L-ferritin, hepatic membrane (45 g) and cyto-
solic (100 g) extracts were prepared from the same liver
samples18 and were resolved on 14% SDS-polyacryl-
amide gels. Proteins were transferred from the gels to
Hybond-ECL nitrocellulose membranes (Amersham Life
Sciences, Little Chalfont, UK). The membranes were ini-
tially blocked by gentle agitation in Tris-buffered saline
with 0.15% Tween 20 (TBST), containing 5% fat-free
dried milk, at room temperature for 1 hour. This was
followed by overnight incubation at 4°C with the following
primary rabbit antibodies: polyclonal antibodies raised
against mouse Fpn and DMT1 (which cross-react with
pig proteins7 and antisera raised against recombinant
mouse light chain ferritin (L-Ft, a gift from Dr. Paolo San-
tambrogio, Milano, Italy) diluted in TBST containing 1%
dried milk. After briefly washing in TBST, the membranes
were then incubated for 1 hour at room temperature with
peroxidase-conjugated anti-rabbit secondary antibody
(Santa Cruz Biotechnology, Santa Cruz, CA). Following a
final wash in TBST, immunoreactive bands were detected
using the ECL Plus enhanced chemiluminescence detec-
tion system (Amersham Life Sciences).
Immunochemistry and Immunofluorescence
Duodenal tissues were processed as previously de-
scribed.18 Briefly, tissues were fixed in paraformalde-
hyde solution, dehydrated and followed by embedding in
paraffin. Five-micrometer sections were deparaffinized in
xylene and rehydrated for staining. For immunohisto-
chemistry only, endogenous peroxidase activity in the
deparaffinized sections was blocked with ethanol 70%-
peroxide 1% solution. Sections were then incubated in
PBS/100 mmol/L glycine, rinsed in PBS, and blocked for
at least 1 hour at room temperature in PBS containing 1%
bovine serum albumin and 10% normal goat serum
(GIBCO). Incubation with the primary antibody diluted in
blocking solution was performed in a wet chamber over-
night at 4°C. Immunohistochemical staining of fixed par-
affin-embedded sections was performed using the per-
oxidase/antiperoxidase diaminobenzidine procedure
(Dako). Sections were then counterstained with H&E, and
mounted in Permount. For immunofluorescence, after in-
cubation with the primary antibodies, sections were fur-
ther incubated with an anti-rabbit secondary antibody
conjugated to Alexa488. Sections were then washed with
PBS and directly mounted with antifading mounting re-
agent (Prolong Antifade kit P-7481 MolecularProbes) and
processed for microscopy. Sections were visualized us-
ing epifluorescence microscope LEICA DM-IRM with a
60 oil immersion objective.
DNA Isolation and Determination of 8-Oxo-7,8-
Dihydro-2-Deoxyguanosine Content
DNA from pig livers was isolated and the content of
8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxodG) was
determined using the high pressure liquid chromatogra-
phy electrochemical detection technique as described
previously.19
Table 1. Oligonucleotide Primers Used for Real-Time Quantitative RT-PCR Analysis
mRNA Forward primer Reverse primer
Amplified
fragment
(bp) Accession number
Apex1 5-GAATGCTGGCTTCACTCCACA-3 5-AAAGGTGTAGGCATACGCCGT-3 115 NM_001139471
Hamp 5-CGCAGCAGAAGATGCAGAT-3 5-CGCAGCAGAAGATGCAGAT-3 115 AF516143
Gapdh 5-GACCACAGTCCATGCCATCAC-3 5-TCCACCACCCTGTTGCTGTAG-3 452 NM_017370
18S 5-ATCCTTCGATGTCGGCTCTT-3 5-ACTAACCTGTCTCACGACGGTC-3 115 CX059405.1
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DNA Repair Activity Assay
The DNA repair activities of APEX and OGG1 in piglet
livers were measured by the nicking assay.20 Liver frag-
ments were homogenized with four volumes of the ap-
propriate buffer, disrupting the cells by sonication. Cell
debris was removed by centrifugation, and the superna-
tants used as the source of DNA repair enzymes. Oligo-
nucleotides (40-mers) containing a single 8-oxo-guanine
or an apurinic/apyrimidinic (AP) site at position 20 in the
sequence 5-d(GCTACCTACCTAGCGACCTXCGACTG-
TCCCACTGCTCGAA)3(Eurogentec Herstal, Belgium
or MetaBion, Germany)—where X indicates either 8-oxo-
guanine or an AP-site—were 32P-labeled at the 5-end
and purified on Micro-Bio-Spin-30 chromatography col-
umns as described by the manufacturer (Bio-Rad). These
were annealed, at a twofold molar excess, to comple-
mentary unlabeled oligodeoxynucleotides, and the for-
mation of duplexes was verified by native 20% polyacryl-
amide gel electrophoresis. The oligodeoxynucleotide
duplexes were incubated with the tissue extracts for 1
hour at 37°C, and the reaction products separated by
denaturing 20% polyacrylamide gel electrophoresis. A
digital image of the separated radioactive products was
prepared by scanning the gel using a phosphorimager
and the band intensities quantified with ImageQuant soft-
ware (Molecular Dynamics, version 5.2). From each data
set, a Michaelis-Menten curve was plotted and the en-
zyme activity calculated. All activity assays were per-
formed at least in triplicate. Two control reactions were
used in each experiment: 1) a negative control in which
the nontreated labeled oligonucleotide duplex was sub-
jected to denaturing PAGE to show if any nonspecific
degradation had occurred during the procedure; 2) a
positive control in which the oligonucleotide duplex was
digested with an excess of the appropriate purified DNA
glycosylase.
Statistical Evaluation
Data are presented as mean values  SD. Assumptions
of normality and equal variance were tested before para-
metric analyses based on two-way analysis of variance
(factors: time and dose), with individual comparisons
made using the Student-Neuman-Keuls post hoc test.
When these assumptions could not be confirmed, non-
parametric analysis was performed using Kruskal-Wallis
analyses of variance, followed by the Mann-Whitney U-
test. Statistical significance was considered at P  0.05
and P  0.01. Statistica for Windows software (version
5.0) was used for the statistical analysis.
Results
Iron Supplementation Prevents a Decrease in
the RBC Indices of Newborn Piglets
Evaluation of the hematological parameters of 1- and
2-day-old piglets clearly showed that these animals were
verging on borderline anemia (Figure 2, A–D). Without
iron supplementation their hematological status gradually
and significantly worsened. On day 14 after birth, low
values for RBC count, hematocrit percentage, hemoglo-
bin concentration and mean erythrocyte volume together
with decreased serum iron level (Figure 3A) indicated the
occurrence of severe iron deficiency anemia. Both iron
treatments efficiently prevented the deterioration of the
hematological status of newborn piglets and contributed
to the recovery of animals from the pre-anemic state
observed by postnatal day 2. The first dose of iron (40 mg
Fe/kg b.w.) given to piglets according to the split supple-
mentation protocol (Figure 1) was at least as effective as
the single high dose (100 mg Fe/kg b.w.), used in tradi-
tional supplementation, at improving the values of the
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Figure 2. Hematological parameters of
control and FeDex-supplemented pig-
lets. Blood cell indices were determined
for 5 to 6 piglets from each group at
each time point. Red blood cell (RBC)
count (A); Hemoglobin (Hb) concentra-
tion (B); Hematocrit (HCT) value (C);
and mean cell volume (MCV) (D). Val-
ues are expressed as the mean  SD.
The values at points indicated by at
least one different letters differ signifi-
cantly (P  0.05).
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hematological parameters up to day 7. The second in-
jection of iron, given according to the modified protocol,
sustained a gradual increase in the values of all analyzed
RBC parameters. On day 14 after birth, piglets from both
groups that had received supplemental iron showed no
significant difference in their hematological profiles.
Relationship Between Iron Status of Piglets and
Hepatic Hepc mRNA Level
Iron was the first biological factor shown to induce hep-
cidin expression21 and there is experimental evidence
that both high iron saturation of plasma transferrin22 and
hepatic iron loading21 stimulate Hepc synthesis. The re-
lationship between hepatic non-heme iron content, serum
iron leve,l and hepatic Hepc mRNA abundance was ex-
amined in control and iron-supplemented piglets. De-
spite their low hepatic iron content and serum iron level,
1- and 2-day-old piglets showed relatively high hepatic
Hepc transcript abundance (Figure 3, B and C), similar to
that of 200-day-old adult pigs with a much higher liver
iron content (see Supplemental Figure 1S at http://ajp.
amjpathol.org). The observed decrease in hepatic iron
content and serum iron level in control piglets after day 2,
was associated with a parallel decline in Hepc mRNA
levels (Figure 3C). Iron supplementation on day 3 (either
40 or 100 mg Fe/kg b.w.) efficiently improved the iron
status of piglets and slightly elevated liver Hepc expres-
sion 24 hours after administration (ie, on day 4). On
postnatal day 7 the piglets injected with 100 mg Fe/kg
b.w. had a greater hepatic iron content and higher serum
iron level than those supplemented with 40 mg Fe/kg
b.w., but there were no noticeable differences in Hepc
mRNA level between these two groups. During the final
stage of the experiment, pigs supplemented with iron in
the traditional manner still maintained a high level of
Hepc expression, whereas animals supplemented by the
split protocol showed only residual expression similar to
that of anemic piglets on day 14 (Figure 3C).
Levels of DMT1 and Fpn in the Duodenal
Mucosa of Newborn Piglets
DMT1 and Fpn protein levels in membrane extracts from
duodenal mucosa scrapings were measured in control
anemic piglets to determine their molecular potential for
iron absorption. On day 1 after birth both DMT1 and Fpn
were barely detectable, and on day 2 these two iron
transporters were expressed at a very low level (Figure
4). The expression of DMT1 increased dramatically by
day 4 and thereafter remained at a slightly lower level. A
similar although less pronounced compared with DMT1
increase in expression was observed in the case of Fpn.
One can note some differences between day 4, 7, and 14
in apparent molecular weigh of both DMT1 and Fpn.
Such changes in protein migration in gel electrophoresis
may reflect some changes in post-translational modifica-
tions of the protein species detected. Indeed, duodenal
(adult) pig Fpn was shown to be post-translationally mod-
ified by complex N-linked glycosylation.7 At day 7, when
both Fpn and DMT1 levels are high, we looked at the
subcellular localization of the two transporters in the du-
odenum of control piglet. Using both immunofluores-
cence technique or classical immunohistochemistry on
duodenal section, we observed the opposite and com-
plementary localization of DMT1 and Fpn (Figure 4B).
DMT1 was strongly detected in the villi at the apical site
of enterocytes corresponding to the brush border
whereas Fpn was found exclusively at the basolateral
membrane of absorptive enterocytes. This localization in
the piglet duodenum is in accordance with previous lo-
calization observed in mouse duodenum and attested of
the specificity of the antibodies used. A comparison of
the duodenal Fpn and DMT1 protein levels in piglets
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Figure 3. Correlation between serum iron level, hepatic non-heme iron
content and hepatic hepcidin mRNA abundance in control and FeDex-
supplemented piglets. Serum iron levels (A) and hepatic non-heme iron
content (B) in control and FeDex-supplemented piglets. Values are ex-
pressed as the mean  SD for serum and liver samples obtained from 5 to 6
piglets at each time point. The values at points indicated by at least one
different letters differ significantly (P  0.05). C: Hepc mRNA abundance in
piglet livers measured by real-time RT-PCR analysis. Each point represents
the mean  SD of two amplification reactions, performed on a single cDNA
sample reverse-transcribed from separate RNA isolated from 5 to 6 different
piglets. Values were normalized against the level of transcript encoding
glyceraldehyde-3-phosphate dehydrogenase. The level of Hepc mRNA level
in control piglets (day 1) was assigned the value of 100%.
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supplemented with FeDex and in controls was next per-
formed using western analysis (Figure 4A). Such analysis
revealed an unexpected up-regulation of Fpn in animals
receiving intramuscular iron injections (Figure 4A, right-
middle panel). Moreover, Fpn levels tended to be higher
in piglets supplemented twice with 40 mg Fe/kg b.w.
than in traditionally-supplemented animals, especially
on day 4 after birth. In contrast to the control piglets,
duodenal Fpn expression in FeDex-supplemented an-
imals (Figure 4A, right-middle panel) showed no rela-
tionship with hepatic hepcidin mRNA levels (Figure
3C). Considering that the Fpn mRNA bears an iron-
responsive element within its 5 UTR, ie, a binding site
for iron regulatory proteins,23 the possibility that Fpn is
up-regulated in FeDex-supplemented piglets by an
iron-mediated posttranscriptional mechanism was ex-
amined. However, a comparison of the iron-responsive
element-binding activity of iron regulatory protein-1 in
the duodenum showed no difference between piglets
from the three experimental groups (see Supplemental
Figure 2S at http://ajp.amjpathol.org).
Histological Evidence of Massive Hepatic Iron
Accumulation in Piglets Supplemented with a
High Amount of Iron Dextran
Microscopic analysis of liver sections stained for non-
heme iron with Perls’ Prussian blue showed heavy iron
deposits in the Kupffer cells of piglets supplemented with
100 mg Fe/kg b.w. (Figure 5A, bottom panel). This mac-
rophagic iron accumulation was observed 24 hours after
the injection of FeDex (Day 4) and was maintained until
the end of the experiment (Day 14). In comparison, the
iron accumulation in the livers of piglets supplemented
twice with 40 mg Fe/kg b.w. was definitely smaller follow-
ing the first FeDex injection and had decreased slightly
when examined again on postnatal days 7 and 14 de-
spite the second FeDex injection on day 10 (Figure 5A,
middle panels). In anemic piglets receiving no supple-
mental iron, hepatic non-heme iron was not detected by
Prussian blue staining (Figure 5A, top panels). To identify
the main non-heme iron-containing compounds in the
livers of piglets supplemented with FeDex, liver mem-
brane extracts were resolved on polyacrylamide gels and
specific staining was used to detect non-heme iron. It
was found that FeDex constituted a major part of the
hepatic iron in the traditionally-supplemented piglets
(Figure 5B, upper panel). The amount of FeDex succes-
sively decreased throughout the experimental period but
was still present in the livers of 14-day-old piglets. In the
liver extracts from piglets given the modified supplemen-
tation protocol only a low concentration of FeDex was
detected at day 4 after birth, following the first injection of
40 mg Fe/kg b.w. At later time-points, FeDex was unde-
tectable in the liver of piglets from this group. The major
endogenous iron-containing protein found in the liver is
ferritin. Iron ferritin saturation in hepatic membrane ex-
tracts was detected by specific staining of ferritin-bound
iron after separation by PAGE.16 It was found to be very
high (comparable with that of purified horse spleen holo-
ferritin, Figure 5B, upper panel) in piglets injected with
the 100 mg Fe/kg b.w. dose. However, iron bound to
ferritin was not detected in the extracts from piglets re-
ceiving two injections of 40 mg Fe/kg b.w. or in those of
animals receiving no supplemental iron. Semiquantitative
analysis of the total content of ferritin in hepatic mem-
brane extracts performed by Coomassie blue staining
after separation by PAGE shows high levels of Ft in
piglets receiving a single high dose of FeDex (Figure 5B,
lower panel). Similarly, more detailed and precise West-
ern blot analysis of L-Ft (a dominant form of ferritin in the
liver) in hepatic membrane extracts reveals increased
amount of light chain Ft in this group of piglets (Figure 5C,
upper panel). Surprisingly, Western blot analysis showed
no major changes in the amount of cytosolic L-Ft between
piglets from different groups (Figure 5C, lower panel).
Hepatic Level of 8-oxodG Is Increased in FeDex
Supplemented Piglets
Numerous studies have highlighted the role of iron in
oxidative stress and damage to DNA (24 and the refer-
Figure 4. Duodenal ferroportin (Fpn) and divalent metal transporter 1
(DMT1) protein levels in anemic non-supplemented and FeDex-supple-
mented piglets. A: DMT1 and Fpn levels in duodenum membrane protein
extracts (100 g/lane) as assessed by Western blotting. Ponceau Red staining
of transferred proteins is shown to confirm similar loading. In addition,
identical blot reacted with actin antibody is shown to confirm equivalent
loading. The presented data are representative of Western blotting analyses
of duodenum membrane extracts obtained from three piglets at each time
point. B: Cellular localization of DMT1 and Fpn in duodenal tissues sections
of control piglet at day 7. By immunofluorescence (left panels, green) of
immunohistochemistry (right panels, brown staining) DMT1 and Fpn were
strongly detected at the apical brush border and basolateral membrane
respectively (see arrows and high magnification inset).
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ences therein). The base modification 8-oxodG is re-
garded as a good biomarker of oxidatively damaged
DNA (for review see 25). The hepatic level of this oxida-
tive DNA adduct was analyzed in piglets receiving sup-
plemental iron and control animals. There was a statisti-
cally significant elevation of the level of 8-oxodG in DNA
isolated from the livers of 4-day-old iron-supplemented
piglets (ie, 1 day after injection of either 100 or 40 mg
Fe/kg b.w.) in comparison with nonsupplemented ani-
mals (Figure 6). Supplementation with a single high dose
of iron resulted in a higher although nonsignificant in-
crease in the 8-oxodG level when compared with the
piglets on the split supplementation protocol. On day 7
this difference was highly statistically significant as the
hepatic level of 8-oxodG in piglets supplemented with
100 mg Fe/kg b.w. was about double the value found in
both control piglets and those supplemented with the
lower dose of 40 mg Fe/kg b.w. By postnatal day 14 the
difference between the control and supplemented piglets
was no longer significant although the latter animals still
showed slightly raised hepatic levels of 8-oxodG.
Modulation of the Expression and Activity of
DNA Repair Enzymes in the Liver of Newborn
Piglets
Transcription of some DNA repair genes, including those
participating in 8-oxodG repair such as APEX, MutT, and
to a lesser extent OGG1, is greatly stimulated by reactive
oxygen species (for review see 26). The administration of
FeDex to 3-day-old piglets was found to increase the
level of APEX transcript in the liver independently of the
schedule of administration (Figure 7A). When examined
the day after administration, the single high FeDex dose
had caused an increase in APEX transcription of over
32-fold and this stimulation persisted for at least the next
four days (until day 7). However, by day 14 the APEX
mRNA level had fallen below that found in nonsupple-
mented animals. Administration of the low and split iron
dose resulted in a moderate (9.5-fold) induction of APEX
mRNA. This induction was only observed on the day
after FeDex administration, and by postnatal day 7. The
level of APEX transcript had decreased to the control
value, and it had dropped below the control by day 14
(Figure 7A).
Figure 5. Hepatic iron status/distribution and ferritin level in control and
FeDex-supplemented piglets. A: Histological examination of iron loading in
liver samples. Non-heme iron deposits were detected by staining with Perls’
Prussian blue and the cells counterstained with nuclear red. Blue staining
was present exclusively in the Kupffer cells of FeDex-supplemented piglets.
A high magnification of Kupffer cells presenting deposits of iron or their
absence in FeDex-supplemented piglets and control animals, respectively is
shown (insets in the top, middle, and bottom right panels). B (upper
panel): Potassium ferricyanide staining of iron-bound ferritin and iron dex-
tran in hepatic membrane extracts from FeDex-supplemented piglets. Iron
saturated horse spleen holo-ferritin (holo-Ft) and iron dextran (FeDex) were
used as positive controls. Horse spleen apo-ferritin (apo-Ft) was used as
negative control. B (bottom panel): Membrane proteins from liver (45
g/lane) were separated on non-denaturing PAGE (as in B), and stained with
Coomassie blue. To assist identification of Ft bands horse spleen holo- and
apo-Ft were used as positive controls (electrophoresed on the same gel). C:
L-Ft levels were assessed in membrane (upper panel) and cytosolic (lower
panel) extracts by Western blotting as described in the Materials and Methods
section. To assist identification of L-Ft bands, recombinant mouse L-Ft (rL-Ft,
a gift from Dr Paolo Santambrogio) was electrophoresed on the same gel.
Blots were also reprobed with monoclonal anti--actin antibody as a loading
control The analyses were performed using liver sections and extracts ob-
tained from three to four different piglets, and representative results are
presented.
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Figure 6. Levels of 8-oxodG in liver DNA of control and FeDex-supple-
mented piglets. Values are expressed as the mean  SD for analyses of liver
DNA samples obtained from five to six piglets at each time point. Asterisks
indicate significant differences (P  0.05).
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Since the activity of DNA repair enzymes may be reg-
ulated via different modes, we verified the effect of iron
administration on the ability of the piglet liver extracts to
cleave abasic sites. The day after the administration of
the single high iron dose, the rate of cleavage of the
oligodeoxynucleotide with a single abasic site had in-
creased by about threefold (Figure 7B). This APEX activ-
ity then decreased gradually: it was still higher than in
control animals on day 7, but by day 14 it had dropped to
below the control value. The lower, split dose of iron
resulted in moderate and short-term APEX induction. The
APEX activity was increased on the day after administra-
tion of the first dose, but was similar to the control values
when examined on day 7, and on day 14, following the
second dose.
The rate of 8-oxoG excision was also increased on the
day after the administration of both doses of iron (Figure
8). Unexpectedly, the excision rate was higher in animals
receiving the lower, split dose of FeDex, than in those
receiving the single high dose. This was observed on day
4 and day 14, while on postnatal day 7, 8-oxoG excision
activities were the same in both groups receiving iron
supplementation, but they were still higher than in the
control animals.
Discussion
IDA is probably the most prevalent micronutrient defi-
ciency disorder in pigs and the most frequent form of
anemia in mammals.3 The goal of the present study was
to investigate the molecular regulation of iron absorption
in IDA of neonatal piglets and to evaluate the benefits and
risks of iron supplementation during the first 2 weeks after
birth. The major etiological factors in pig IDA include low
fetal iron stores, the high intensity of piglet growth, in-
creasing litter size, and inadequate levels of iron in sow’s
milk.3,27 However, little is known about the molecular
regulation of iron absorption in suckling piglets during the
immediate postpartum period. A number of studies have
demonstrated the limited efficacy of dietary iron supple-
ments in preventing pig IDA.28,29 The poor responsive-
ness of piglets to oral iron therapy strongly suggests
some immaturity in the molecular machinery of duodenal
iron absorption. Indeed, we have demonstrated that the
expression of DMT1 and Fpn, two iron transporters criti-
cal for intestinal iron absorption, was barely detectable
during the two first days of life and only started to in-
crease at around the fourth day after birth. This timing
coincides with the replacement of “fetal-type” entero-
cytes with the “adult-type” lacking the apical canalicular
system responsible for the absorption of bioactive pro-
teins and peptides.30 After day 4, the two transporters are
strongly expressed at their known site of activity in en-
terocytes Similar DMT1 and Fpn expression profiles have
also been reported during early infant development in
rat31 and mouse pups.32 Taken together these data sug-
gest that mechanisms of iron absorption that function in
adults may not be fully developed in neonatal mammals.
Alternatively, in the case of Fpn its low expression in
piglets observed in the 2 days after birth may be a
consequence of high hepatic Hepc expression, which is
consistent with the current concept of Fpn down-regula-
tion by Hepc.33 High Hepc expression in newborn piglets
is puzzling considering their low hepatic iron content.
Interestingly, high levels of Hepc mRNA have previously
been observed in rats21 and mice34 in the perinatal pe-
riod. It is known that the birth process initiates an acute
Figure 7. APEX mRNA level (A) and AP-site incision activity (B) in the livers
of control and FeDex-supplemented piglets. A: APEX transcript abundance in
piglet livers was measured by real-time RT-PCR analysis. Reactions and data
presentation are as described in the legend to Figure 3C except that the
values were normalized against the level of 18S rRNA. The level of APEX
mRNA in control piglets (day 1) was assigned the value of 100%. B: APEX
DNA repair activity in piglet livers was measured by the nicking assay. Values
are expressed as the mean  SD for analyses of liver DNA samples obtained
from five to six piglets at each time point. Asterisks indicate significant
differences (*P  0.05, **P  0.01).
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Figure 8. 8-OxoGua excision activity in the livers of control and FeDex-
supplemented piglets. OGG1 DNA repair activity in piglet livers was mea-
sured by the nicking assay. Values are expressed as the mean  SD for
analyses of liver DNA samples obtained from five to six piglets at each time
point. Asterisks indicate significant differences (P  0.05).
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phase response in the healthy fetus-newborn infant with
increased circulating levels of interleukin-6,35 a well-
known inflammatory cytokine that is responsible for the
induction of Hepc during inflammation.36 Surprisingly, in
contrast to anemic piglets, the Hepc-Fpn regulatory axis
in FeDex-supplemented animals appeared to be non-
functional. A possible explanation for this phenomenon
may be that systemic regulation of Fpn is immature in
newborn piglets.2,37 Alternatively, there is evidence
showing that in contrast to hepatic Fpn, duodenal Fpn is
poorly sensitive to the rise in Hepc levels.38,39 Finally,
although Hepc mRNA expression is most preferred in
animal studies, its correlation with circulating bioactive
Hepc (a 25-amino acid peptide) levels is largely un-
known. Several suitable serum Hepc assays have been
developed mostly for humans.40,41,42 However, recent
results of the first international round robin for the quan-
tification of urinary and plasma hepcidin assays show
that more work is needed for the use of Hepc plasma
evaluation in experimental and clinical application.43
Several cases of iron toxicity have been reported on
the commonly practiced administration of large amounts
of FeDex in a single intramuscular injection.28,44 To opti-
mize efficacy in correcting IDA, and minimize iron toxicity
and Hepc synthesis we have tested a split supplemen-
tation protocol by which to give exogenous iron to piglets
at an early age. Our results clearly show that this modified
parenteral FeDex therapy satisfies all of the requirements
of a method for administering iron to piglets. First, the
modified iron supplementation efficiently prevents the de-
crease in the main RBC indices. Second, under this split
protocol the stimulatory effect of parenteral iron on Hepc
mRNA expression is completely lost after the second
dose of FeDex, whereas the traditional use of a single
high dose results in a sustained hepatic Hepc mRNA
increase. In accordance with the proposed role of circu-
lating holo-transferrin in signaling the increase in Hepc
expression in hepatocytes,45 it is tempting to propose
that the delayed drop in hepatic Hepc mRNA level in
piglets receiving split supplementation is directly linked
to the continuously decreasing serum iron concentration.
In this group of piglets, iron released from FeDex in-
gested by Kupffer cells (known to accumulate iron after
FeDex injection in animals)46 appears to be rapidly recy-
cled into the circulation to be preferentially used in the
process of enhanced erythropoiesis and is provided in
limited amounts to the parenchyma of the liver to induce
Hepc synthesis. Indeed, the analysis of non-heme iron
content and its cellular distribution in the liver of piglets
receiving two doses of 40 mg Fe/kg b.w. showed no
substantial iron accumulation in liver cells. In contrast,
Kupffer cells from traditionally-supplemented piglets dis-
played strong Prussian blue iron staining throughout the
experimental period. Moreover, the pattern of molecular
iron distribution provided evidence of high ferritin satura-
tion with iron and the persistence of large amounts of
intact FeDex. These histological data corroborate the
findings of postmortem examination of the visceral, limb
and neck lymph nodes. The lymph nodes in piglets sup-
plemented with 100 mg Fe/kg b.w. were much more biger
and darker than those of piglets supplemented with 40
mg Fe/kg b.w. (data not shown). Accordingly, after i.m.
FeDex injection iron enters the RES through the lymphatic
circulation. A detailed analysis of Ft expression at the
protein level shows high amount of iron-rich Ft in hepatic
membrane extracts (supposed to contain lysosomal frac-
tion) in piglets receiving a single high dose of FeDex, and
no major difference in the level of cytosolic L-Ft. We
hypothesize that in piglets injected with a single high
dose of FeDex, large amount of iron released from this
compound is efficiently detoxified by cytosolic Ft, which
is then rapidly taken into the lysosomes and degraded. It
has been shown previously that iron-laden Ft molecules
are preferentially eliminated from the cytosol and are
faster taken up by lysosomes than normally iron-satu-
rated molecules.47 The appearance of siderosomes
(heavily iron-laden terminal lyzosomes) has been also
demonstrated under conditions of iron overload - in rats
given injections of iron dextran.48 Vast amount of solubi-
lized iron from the ferric core of degraded Ft molecules
could then induce intralysosomal iron-catalyzed oxidative
reactions with damage to lysosomal membranes and
leakage of destructive contents.
When in excess, iron is toxic because it generates the
hydroxyl radical that reacts readily with biological mole-
cules. Therefore, besides efficacy in correcting iron de-
ficiency, one of the main criteria for selecting an iron
supplementation protocol is that the supplemental iron
should produce minimal toxicity. The oxidatively dam-
aged DNA exacerbated by iron may be involved in the
development of various pathological conditions (for re-
view see 25, 49). Considering the striking differences in
the hepatic non-heme iron content found in piglets from
the three experimental groups, 8-oxodG was used as a
biomarker of iron-induced oxidative stress in piglet livers.
In our previous study we observed a strong correlation
between iron content and levels of the oxidatively modi-
fied nucleoside in lymphocytes’ DNA.24 The results of the
present study also showed that points with the highest
iron concentrations were related to the highest 8-oxodG
levels. Furthermore, the modified iron supplementation was
linked with a significantly smaller increase in 8-oxodG level
in hepatic DNA compared with the traditional protocol.
These findings strongly suggest that the split supplemen-
tation of piglets with FeDex minimizes the potential of
parenteral iron therapy to induce oxidative stress and
DNA damage.
The extent of oxidatively damaged DNA is also depen-
dent on the efficiency of DNA repair systems. The main
pathway to remove 8-oxoGua from DNA is base excision
repair (BER) initiated predominantly by OGG1 glycosy-
lase.50 The activity of this enzyme is regulated by the next
enzyme of the BER pathway: abasic sites endonuclease
(Apex1). We observed an iron-triggered increase in lev-
els of Apex1 mRNA, which was particularly large follow-
ing supplementation with the single high dose of iron. The
transcription of APEX is known to be induced by oxidative
stress.51 The ability of liver extracts to incise abasic sites
was also increased in the livers of animals supplemented
with iron, and this induction was higher in piglets receiv-
ing a single high dose of FeDex than when two smaller
doses were given in the split protocol. The increase in
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APEX activity was transient and decreased to the control
level on the seventh day of life in animals receiving a split
dose of iron, but remained high in the group receiving the
single dose. Similarly, an increased rate of 8-oxoGua
excision was observed up to day 14 of the experiment in
the livers of piglets supplemented with FeDex by the two
different protocols. OGG1 is a housekeeping gene,52
which may also be induced by oxidative stress.53 On
postnatal days 4 and 14, higher 8-oxoGua excision ac-
tivity was observed in animals treated with the split dose
than with a single high dose of FeDex. One possible
explanation is inhibition of OGG1 activity by inflammation
caused by iron overload in the livers of piglets treated
with the single high dose of iron. OGG1 activity is inhib-
ited by an inflammatory process that was shown to be
produced in response to the administration of a high iron
dose in rats.54 In this study, piglets supplemented with a
single high dose of FeDex were found to be particularly
prone to unbalanced DNA repair activity. Since the dif-
ferences in the repair rate of the two studied enzymes
were smaller following a split dose of iron, this modified
supplementation protocol may be beneficial.
In summary, the results of this study provide evidence
that the molecular regulation of iron absorption in new-
born anemic piglets is immature, which possibly explains
the poor responsiveness of these animals to oral iron
therapy. Our findings also show that parenteral iron sup-
plementation has to be based on a tight balance between
possible benefits and risks: the efficacy of iron supple-
ments in combating anemia and the generation of oxida-
tive damage due to iron excess.
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